GlassScriptPhysician profile
Kevin Finnegan
NPI 1629630199
$1,308.94
in general payments reported to CMS, 2019-2025
18 companies · $168 in 2025
The $168 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $315 · 2022: $472 · 2023: $196 · 2024: $158 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $521.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $442.11 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Janssen Pharmaceuticals, INC | $214.54 | 2021-2024 | Xarelto |
| Lemaitre Vascular, INC. | $102.64 | 2022-2025 | Artegraft Vascular Graft |
| Organogenesis INC. | $87.70 | 2024-2025 | Puraply Wound Matrix, Cygnus Dual, Simplimax |
| Getinge USA Sales, LLC | $69.80 | 2022-2025 | Flixene |
| Pfizer INC. | $68.98 | 2021-2023 | |
| Veryan Medical Incorporated | $47.13 | 2021 | |
| Siemens Medical Solutions USA, INC. | $38.62 | 2022-2024 | Artis Pheno |
| Silk Road Medical, INC. | $38.20 | 2022-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Medtronic, INC. | $33.66 | 2021 | |
| Abbvie INC. | $31.87 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $30.61 | 2022 | |
| Amgen INC. | $21.62 | 2021 | |
| Baxter Healthcare | $18.58 | 2025 | Floseal |
| Tactile Systems Technology INC | $17.79 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $15.57 | 2021 | |
| Hydrofera LLC | $15.17 | 2023 | Hydrofera Blue |
| Endologix LLC | $14.35 | 2023 | Afx2 Bifurcated Endograft System, Ovation Ix Iliac Stent Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Finnegan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.